Our objective

We strive to further develop and improve existing cancer therapies. In clinical trials, we investigate whether new treatments are effective, well-tolerated and safe. The obtained findings have a direct impact on clinical practice and offer an immediate benefit to patients. 

We are comprised of a national network of hospitals and also collaborate with hospitals and study groups abroad. We are particularly well-connected within the oncological research community in Europe: we conduct clinical trials in cooperation with foreign trial groups, assuming the role of representative for the foreign sponsor in Switzerland, while foreign trial groups and individual hospitals abroad also take part in SAKK trials.

More than research

We provide cancer patients in Switzerland with the opportunity to receive treatment within the framework of a clinical trial. However, our trials are more than research: through our work, we make a substantial contribution to the quality assurance of oncological treatments and the practice of evidence-based medicine.